FindMyRecallSubscribe
Class I: serious health riskTerminated

Aurobindo Pharma Ampicillin and Sulbactam for Injection 1 Recall

Ampicillin and Sulbactam for Injection 1

Aurobindo Pharma Ltd. · Hyderabad, N/A

Risk level
Class I
Reported by FDA
Feb 14, 2018
Recall ID
D-0339-2018
Check your lot numberHow we source this data

Summary

Aurobindo Pharma recalled Ampicillin and Sulbactam for Injection 1 starting Jan 2, 2018. The FDA classified it as Class I (serious health risk) and published enforcement report D-0339-2018 on Feb 14, 2018. Reason: Presence of Particulate Matter: A confirmed customer report was received for the presence of visible particulate matter, confirmed as glass, within a single vial. Status: Terminated.

Why it was recalled

Presence of Particulate Matter: A confirmed customer report was received for the presence of visible particulate matter, confirmed as glass, within a single vial.

Product description

Ampicillin and Sulbactam for Injection 1.5 g vial, sterile Dry Powder for injection, 10 vials per carton, Distributed by AuroMedics Pharma LLC. 279 Princeton-Highstown Rd. E. Windsor, NJ 08520, NDC 55150-116-20

Lot numbers, UPCs & expiration codes

Lot Number AF0117001-A

Where it was sold

distributed nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0339-2018
Classification
Class I
Status
Terminated
Recall initiated
Jan 2, 2018
FDA report date
Feb 14, 2018
Quantity
53,040 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Aurobindo Pharma Ltd.

Original FDA data

Every field from FDA enforcement report D-0339-2018, exactly as published.

Show all FDA fields
City
Hyderabad
Status
Terminated
Country
India
Event ID
78847
Address
Unit Xii, Lactam Formulation Plant
Address (line 2)
Survey No. 314, Bachupally, Quthbullapur
Code information
Lot Number AF0117001-A
Report date
Feb 14, 2018
Product type
Drugs
Recall number
D-0339-2018
Classification
Class I
Recalling firm
Aurobindo Pharma Ltd.
Product quantity
53,040 vials
Termination date
Sep 10, 2019
Reason for recall
Presence of Particulate Matter: A confirmed customer report was received for the presence of visible particulate matter, confirmed as glass, within a single vial.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Ampicillin and Sulbactam for Injection 1.5 g vial, sterile Dry Powder for injection, 10 vials per carton, Distributed by AuroMedics Pharma LLC. 279 Princeton-Highstown Rd. E. Windsor, NJ 08520, NDC 55150-116-20
Distribution pattern
distributed nationwide in the USA
Recall initiation date
Jan 2, 2018
Initial firm notification
Letter
Center classification date
Feb 8, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0339-2018, published Feb 14, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls